PTHL Pheton Holdings Ltd Class A Ordinary Shares

99

Health Care [ 9/12 ] | Health Care Equipment & Supplies [ 56/74 ]

NASDAQ | Common Stock

Price
$4.65
Increased by +4.73%
Dollar volume (20D)
641.60 K
ADR%
15.58
Shares float
3.18 M
Shares short
41.26 K [1.30%]
Shares outstanding
6.58 M
Market cap
55.68 M
Beta
N/A
Price/earnings
N/A
20D range
2.51 4.70
50D range
1.82 4.85
200D range
1.32 6.45

Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy.

Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.

The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients.

The company was founded in 1998 and is headquartered in Beijing, China.

Pheton Holdings Ltd is a subsidiary of ZJW (BVI) LTD.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY